# Target Gene Sequencing for Advanced Stage, Relapsed or Refractory Natural Killer/T-cell Lymphoma

> **NCT04509804** · — · COMPLETED · sponsor: **Chinese Academy of Medical Sciences** · enrollment: 26 (actual)

## Conditions studied

- Lymphoid Neoplasm

## Interventions

- **OTHER:** non-interventional

## Key facts

- **NCT ID:** NCT04509804
- **Lead sponsor:** Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-10
- **Primary completion:** 2019-09-01
- **Final completion:** 2020-01-01
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2020-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04509804

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04509804, "Target Gene Sequencing for Advanced Stage, Relapsed or Refractory Natural Killer/T-cell Lymphoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04509804. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*